1. Evaluation of serum erythropoietin values as defined by 2016 World Health Organization criteria for the diagnosis of polycythemia vera. Issue 11 (2nd November 2017) Authors: Silver, Richard T.; Krichevsky, Spencer; Gjoni, Stefani; Cross, Nicholas C. P. Journal: Leukemia & lymphoma Issue: Volume 58:Issue 11(2017) Page Start: 2768 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Fedratinib Improves Myelofibrosis-related Symptoms and Health-related Quality of Life in Patients with Myelofibrosis Previously Treated with Ruxolitinib: Patient-reported Outcomes from the Phase II JAKARTA2 Trial. Issue 5 (29th May 2021) Authors: Harrison, Claire N.; Schaap, Nicolaas; Vannucchi, Alessandro M.; Kiladjian, Jean-Jacques; Jourdan, Eric; Silver, Richard T.; Schouten, Harry C.; Passamonti, Francesco; Zweegman, Sonja; Talpaz, Moshe; Verstovsek, Srdan; Tang, Derek; Abraham, Pranav; Lord-Bessen, Jennifer; Rose, Shelonitda; Guo, Sh... Journal: HemaSphere Issue: Volume 5:Issue 5(2021) Page Start: e562 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Fedratinib in patients with myelofibrosis previously treated with ruxolitinib: An updated analysis of the JAKARTA2 study using stringent criteria for ruxolitinib failure. Issue 6 (17th April 2020) Authors: Harrison, Claire N.; Schaap, Nicolaas; Vannucchi, Alessandro M.; Kiladjian, Jean‐Jacques; Jourdan, Eric; Silver, Richard T.; Schouten, Harry C.; Passamonti, Francesco; Zweegman, Sonja; Talpaz, Moshe; Verstovsek, Srdan; Rose, Shelonitda; Shen, Juan; Berry, Tymara; Brownstein, Carrie; Mesa, Ruben A. Journal: American journal of hematology Issue: Volume 95:Issue 6(2020:Jun.) Page Start: 594 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Impact of bone marrow fibrosis grade in post‐polycythemia vera and post‐essential thrombocythemia myelofibrosis: A study of the MYSEC group. Issue 1 (1st November 2019) Authors: Mora, Barbara; Guglielmelli, Paola; Rumi, Elisa; Maffioli, Margherita; Barraco, Daniela; Rambaldi, Alessandro; Caramella, Marianna; Komrokji, Rami S.; Kiladjian, Jean‐Jacques; Gotlib, Jason; Iurlo, Alessandra; Cervantes, Francisco; Devos, Timothy; Palandri, Francesca; De Stefano, Valerio; Ruggeri... Journal: American journal of hematology Issue: Volume 95:Issue 1(2020:Jan.) Page Start: E1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Management of CML-blast crisis. Issue 3 (September 2016) Authors: Hehlmann, Rüdiger; Saußele, Susanne; Voskanyan, Astghik; Silver, Richard T. Journal: Baillière's best practice and research in clinical haematology Issue: Volume 29:Issue 3(2016) Page Start: 295 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Myelofibrosis: best practices, controversies and 2019 update. Issue 1 (2nd January 2020) Authors: Cruz, Nicole M.; Gergis, Usama; Silver, Richard T. Journal: Expert review of hematology Issue: Volume 13:Issue 1(2020) Page Start: 71 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. New Perspectives of Interferon-alpha2 and Inflammation in Treating Philadelphia-negative Chronic Myeloproliferative Neoplasms. Issue 12 (18th December 2021) Authors: Hasselbalch, Hans C.; Silver, Richard T. Journal: HemaSphere Issue: Volume 5:Issue 12(2021) Page Start: e645 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Optimal therapy for polycythemia vera and essential thrombocythemia: Preferred use of interferon therapy based on phase 2 trials. Issue 7 (8th August 2016) Authors: Silver, Richard T.; Hasselbalch, Hans Carl Journal: Hematology Issue: Volume 21:Issue 7(2016) Page Start: 387 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Phenotype variability of patients with post polycythemia vera and post essential thrombocythemia myelofibrosis is associated with the time to progression from polycythemia vera and essential thrombocythemia. (June 2018) Authors: Mora, Barbara; Giorgino, Toni; Guglielmelli, Paola; Rumi, Elisa; Maffioli, Margherita; Rambaldi, Alessandro; Caramella, Marianna; Komrokji, Rami; Gotlib, Jason; Kiladjian, Jean Jacques; Cervantes, Francisco; Devos, Timothy; Palandri, Francesca; De Stefano, Valerio; Ruggeri, Marco; Silver, Richard... Journal: Leukemia research Issue: Volume 69(2018) Page Start: 100 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Response to pegylated interferon in a COVID‐19–positive elderly woman with primary myelofibrosis treated with ruxolitinib. Issue 4 (7th March 2021) Authors: Frankel, Arthur E.; Reddy, Renuka; DeSuza, Kayla R.; Deeb, Khaled; Carlin, Aaron F.; Smith, Davey; Xie, Yushuang; Naik, Eknath; Silver, Richard T.; Hasselbalch, Hans C. Journal: Clinical case reports Issue: Volume 9:Issue 4(2021) Page Start: 2228 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗